TY - JOUR T1 - Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19 JO - Anais Brasileiros de Dermatologia T2 - AU - Munhoz,Sandy Daniele AU - Lellis,Rute Facchini AU - Reis,Ana Paula Carvalho AU - Del Negro,Gilda Maria Barbaro AU - Sousa,Maria Glória Teixeira AU - Veasey,John Verrinder SN - 03650596 M3 - 10.1016/j.abd.2022.02.001 DO - 10.1016/j.abd.2022.02.001 UR - http://www.anaisdedermatologia.org.br/en-rhino-orbito-cerebral-mucormycosis-caused-by-rhizopus-articulo-S0365059622000903 AB - COVID-19 disease caused by the SARS-CoV-2 coronavirus causes a wide range of clinical manifestations, ranging from mild to severe, with the main ones affecting the respiratory tract, such as pneumonia. In patients with greater severity, the high frequency of bacterial and fungal coinfection stands out, a situation related both to the patient's pre-existing comorbidities and due to the hospitalization itself. Cases of mucormycosis associated with COVID-19 were highlighted in the lay and scientific media, with the increase in mycosis cases being directly and indirectly attributed to the viral infection. This report describes a case of rhino-orbito-cerebral mucormycosis in a diabetic patient hospitalized for COVID-19, whose diagnosis was confirmed by identifying the agent Rhizopus microsporus var. microsporus through culture for fungi and PCR examination. ER -